Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naveen Premnath

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
HSR26-269: Shifts in the Utilization of Mental Health Services Among US Cancer Survivors Post-COVIDFiza Alam, Naveen Premnath
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
HSR26-269: Shifts in the Utilization of Mental Health Services Among US Cancer Survivors Post-COVIDFiza Alam, Naveen Premnath
Chinese Clinical Oncology|August 14, 2020
BReast CAncer (BRCA) gene mutations as an emerging biomarker for the treatment of gastrointestinal malignanciesNaveen Premnath, Eileen M O'Reilly
Cancers|June 10, 2023
Paradigm Shift in the Management of Acute Myeloid Leukemia-Approved Options in 2023Naveen Premnath, Yazan F Madanat
Cancers|June 10, 2023
Novel Investigational Agents and Pathways That May Influence the Future Management of Acute Myeloid LeukemiaNaveen Premnath, Yazan F Madanat
JCO Global Oncology|May 22, 2020
Potential Cost Savings With Low-Dose Abiraterone in the United StatesNaveen Premnath, Ramy Sedhom, Arjun Gupta
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
EPR26-166: Food Insecurity and Healthcare Utilization Among Cancer Survivors - Pre and Post COVID-19Shruthi Sridhar, Krishna Sajeev, Naveen Premnath
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
EPR26-166: Food Insecurity and Healthcare Utilization Among Cancer Survivors - Pre and Post COVID-19Shruthi Sridhar, Krishna Sajeev, Naveen Premnath
JCO Oncology Practice|April 4, 2020
Park the ParkingNaveen Premnath, Udhayvir Singh Grewal, Arjun Gupta
European Journal of Haematology|June 7, 2023
Possible role of IL-23 inhibitor in autoimmune hemolytic anemiaNaveen Premnath, Urvashi Pandey, Mohak Pandey, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
HSR26-269: Shifts in the Utilization of Mental Health Services Among US Cancer Survivors Post-COVIDFiza Alam, Naveen Premnath
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
HSR26-269: Shifts in the Utilization of Mental Health Services Among US Cancer Survivors Post-COVIDFiza Alam, Naveen Premnath
Chinese Clinical Oncology|August 14, 2020
BReast CAncer (BRCA) gene mutations as an emerging biomarker for the treatment of gastrointestinal malignanciesNaveen Premnath, Eileen M O'Reilly
Cancers|June 10, 2023
Paradigm Shift in the Management of Acute Myeloid Leukemia-Approved Options in 2023Naveen Premnath, Yazan F Madanat
Cancers|June 10, 2023
Novel Investigational Agents and Pathways That May Influence the Future Management of Acute Myeloid LeukemiaNaveen Premnath, Yazan F Madanat
JCO Global Oncology|May 22, 2020
Potential Cost Savings With Low-Dose Abiraterone in the United StatesNaveen Premnath, Ramy Sedhom, Arjun Gupta
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
EPR26-166: Food Insecurity and Healthcare Utilization Among Cancer Survivors - Pre and Post COVID-19Shruthi Sridhar, Krishna Sajeev, Naveen Premnath
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
EPR26-166: Food Insecurity and Healthcare Utilization Among Cancer Survivors - Pre and Post COVID-19Shruthi Sridhar, Krishna Sajeev, Naveen Premnath
JCO Oncology Practice|April 4, 2020
Park the ParkingNaveen Premnath, Udhayvir Singh Grewal, Arjun Gupta
European Journal of Haematology|June 7, 2023
Possible role of IL-23 inhibitor in autoimmune hemolytic anemiaNaveen Premnath, Urvashi Pandey, Mohak Pandey, et al.
Pageof 3